Ubiquitylated histone H2B and ubiquitylated PCNA also decreased, but the overall decrease in ubiquitylated proteins was the most obvious pharmacodynamic biomarker demonstrating that TAK-243 effectively inhibits ubiquitylation in ACC, as consequence of its established E1 inhibitory activity. This evidence concerns the gene PCNA and adrenal cortex carcinoma.